DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset management; and commodity brokerage business. The company was formerly known as SU-Holdings Co.,Ltd. and changed its name to DHX Company Co., Ltd. in December 2024. DHX Company Co., Ltd. was founded in 1979 and is headquartered in Seoul, South Korea.
Metrics to compare | 031860 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship Relationship031860PeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −1.3x | 11.2x | |
PEG Ratio | −0.02 | 0.03 | 0.02 | |
Price/Book | 0.2x | 0.7x | 1.4x | |
Price / LTM Sales | 0.6x | 0.7x | 1.0x | |
Upside (Analyst Target) | - | 29.3% | 21.6% | |
Fair Value Upside | Unlock | 24.8% | 9.9% | Unlock |